JUNSW
Income statement / Annual
Last year (2021), Jupiter Neurosciences, Inc.'s total revenue was $638.04 K,
a decrease of 43.35% from the previous year.
In 2021, Jupiter Neurosciences, Inc.'s net income was -$4.31 M.
See Jupiter Neurosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$638.04 K |
$1.13 M |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$638.04 K
|
$1.13 M
|
$0.00
|
| Gross Profit Ratio |
1
|
1
|
0
|
| Research and Development Expenses |
$1.45 M
|
$1.64 M
|
$685.74 K
|
| General & Administrative Expenses |
$3.10 M
|
$1.34 M
|
$1.49 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.10 M
|
$1.34 M
|
$1.49 M
|
| Other Expenses |
$0.00
|
$0.00
|
$15.37 K
|
| Operating Expenses |
$4.55 M
|
$2.98 M
|
$2.18 M
|
| Cost And Expenses |
$4.55 M
|
$2.98 M
|
$2.18 M
|
| Interest Income |
$132.00
|
$38.00
|
$4.00
|
| Interest Expense |
$113.99 K
|
$13.54 K
|
$317.10 K
|
| Depreciation & Amortization |
$132.00
|
$82.69 K
|
$15.37 K
|
| EBITDA |
-$3.91 M |
-$1.77 M |
-$2.16 M |
| EBITDA Ratio |
-6.12
|
-1.57
|
0
|
| Operating Income Ratio |
-6.12
|
-1.64
|
0
|
| Total Other Income/Expenses Net |
-$293.16 K
|
$196.90 K
|
-$870.06 K
|
| Income Before Tax |
-$4.20 M
|
-$1.65 M
|
-$3.05 M
|
| Income Before Tax Ratio |
-6.58
|
-1.47
|
0
|
| Income Tax Expense |
$113.86 K
|
$13.50 K
|
$317.10 K
|
| Net Income |
-$4.31 M
|
-$1.67 M
|
-$3.36 M
|
| Net Income Ratio |
-6.76
|
-1.48
|
0
|
| EPS |
0 |
0 |
0 |
| EPS Diluted |
0 |
0 |
0 |
| Weighted Average Shares Out |
$0.00
|
$0.00
|
$0.00
|
| Weighted Average Shares Out Diluted |
$0.00
|
$0.00
|
$0.00
|
| Link |
|
|
|
